* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
11156PTP4A3C0009375Colonic Neoplasms0.200549453568426BEFREE;CTD_human
11156PTP4A3C0027627Neoplasm Metastasis0.036134737120274BEFREE;LHGDN
11156PTP4A3C0038356Stomach Neoplasms0.0114811034276812BEFREE;LHGDN
11156PTP4A3C0009404Colorectal Neoplasms0.00819873739444126LHGDN
11156PTP4A3C2239176Liver carcinoma0.0060152784980537BEFREE;LHGDN
11156PTP4A3C1458155Mammary Neoplasms0.0054658249296275LHGDN
11156PTP4A3C0009402Colorectal Carcinoma0.0032967214105572BEFREE
11156PTP4A3C0686619Secondary malignant neoplasm of lymph node0.0030219946263441BEFREE
11156PTP4A3C1527249Colorectal Cancer0.0030219946263441BEFREE
11156PTP4A3C0001418Adenocarcinoma0.00300763924902685BEFREE;LHGDN
11156PTP4A3C0027819Neuroblastoma0.00300763924902685BEFREE;LHGDN
11156PTP4A3C0024623Malignant neoplasm of stomach0.002747267842131BEFREE
11156PTP4A3C0699791Stomach Carcinoma0.002747267842131BEFREE
11156PTP4A3C0007137Squamous cell carcinoma0.00273291246481375LHGDN
11156PTP4A3C0017638Glioma0.00273291246481375LHGDN
11156PTP4A3C0024121Lung Neoplasms0.00273291246481375LHGDN
11156PTP4A3C0919267ovarian neoplasm0.00273291246481375LHGDN
11156PTP4A3C0178874Tumor Progression0.0024725410579179BEFREE
11156PTP4A3C0596263Carcinogenesis0.0021978142737048BEFREE
11156PTP4A3C0007102Malignant tumor of colon0.0016483607052786BEFREE
11156PTP4A3C0678222Breast Carcinoma0.0013736339210655BEFREE
11156PTP4A3C0699790Colon Carcinoma0.0013736339210655BEFREE
11156PTP4A3C0006142Malignant neoplasm of breast0.0010989071368524BEFREE
11156PTP4A3C0023467Leukemia, Myelocytic, Acute0.0008241803526393BEFREE
11156PTP4A3C0025202melanoma0.0008241803526393BEFREE
11156PTP4A3C0029925Ovarian Carcinoma0.0008241803526393BEFREE
11156PTP4A3C0494165Secondary malignant neoplasm of liver0.0008241803526393BEFREE
11156PTP4A3C0220633Uveal melanoma0.0005494535684262BEFREE
11156PTP4A3C0279626Squamous cell carcinoma of esophagus0.0005494535684262BEFREE
11156PTP4A3C1140680Malignant neoplasm of ovary0.0005494535684262BEFREE
11156PTP4A3C1402294Primary Lesion0.0005494535684262BEFREE
11156PTP4A3C1658953tumor vasculature0.0005494535684262BEFREE
11156PTP4A3C0000744Abetalipoproteinemia0.0002747267842131BEFREE
11156PTP4A3C0000768Congenital Abnormality0.0002747267842131BEFREE
11156PTP4A3C0004565Melanoma, B160.0002747267842131BEFREE
11156PTP4A3C0005940Bone Diseases0.0002747267842131BEFREE
11156PTP4A3C0007124Noninfiltrating Intraductal Carcinoma0.0002747267842131BEFREE
11156PTP4A3C0007138Carcinoma, Transitional Cell0.0002747267842131BEFREE
11156PTP4A3C0008487Chordoma0.0002747267842131BEFREE
11156PTP4A3C0019163Hepatitis B0.0002747267842131BEFREE
11156PTP4A3C0023418leukemia0.0002747267842131BEFREE
11156PTP4A3C0023473Myeloid Leukemia, Chronic0.0002747267842131BEFREE
11156PTP4A3C0026470Monoclonal Gammopathy of Undetermined Significance0.0002747267842131BEFREE
11156PTP4A3C0026764Multiple Myeloma0.0002747267842131BEFREE
11156PTP4A3C0041296Tuberculosis0.0002747267842131BEFREE
11156PTP4A3C0085281Addictive Behavior0.0002747267842131BEFREE
11156PTP4A3C0153676Secondary malignant neoplasm of lung0.0002747267842131BEFREE
11156PTP4A3C0269102Endometrioma0.0002747267842131BEFREE
11156PTP4A3C0278883Metastatic melanoma0.0002747267842131BEFREE
11156PTP4A3C0280100solid tumor0.0002747267842131BEFREE
11156PTP4A3C0376358Malignant neoplasm of prostate0.0002747267842131BEFREE
11156PTP4A3C0424295Hyperactive behavior0.0002747267842131BEFREE
11156PTP4A3C0521158Recurrent tumor0.0002747267842131BEFREE
11156PTP4A3C0598766Leukemogenesis0.0002747267842131BEFREE
11156PTP4A3C0600139Prostate carcinoma0.0002747267842131BEFREE
11156PTP4A3C0677886Epithelial ovarian cancer0.0002747267842131BEFREE
11156PTP4A3C0700095Central neuroblastoma0.0002747267842131BEFREE
11156PTP4A3C0853879Invasive carcinoma of breast0.0002747267842131BEFREE
11156PTP4A3C1519670Tumor Angiogenesis0.0002747267842131BEFREE
11156PTP4A3C1531608Smoldering myeloma0.0002747267842131BEFREE
11156PTP4A3C2145472Urothelial Carcinoma0.0002747267842131BEFREE